Multiplikator Forward P/S Guardant360 (GH)

Guardant Health, Inc. (GH) delegates clinical testing and sample transportation to external partners, creating a certain dependency on contractors. The company is implementing innovative liquid biopsy, displacing traditional cancer diagnostic methods. Outsourcing computation optimization and sequencer assembly accelerates the delivery of results. The future P/S ratio demonstrates the boundaries of trading ranges, where the current status equals 16.30.

GH (guardanthealth.com) riwayat Multiplikator Forward P/S saka 04.07.2022 nganti 13.11.2026

Rincian metrik komprehensif lan analitis Guardant Corp (GH)

- rega pasar lan target rega analis:

Bagan rega Guardant Health|GH - Target median analis

- rincian kapitalisasi pasar:

Kapitalisasi pasar Guardant Corp|GH - Nilai Perusahaan Nalika Diakuisisi Penuh

- statistik nilai buku emiten:

Nilai Akuntansi saben Saham Guardant Health|GH - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku guardanthealth.com|GH - Total Aset Perusahaan

- rincian utang lan likuiditas:

Utang marang Ekuitas Guardant Health, Inc.|GH - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Guardant Health, Inc.|GH - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Guardant Corp|GH - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Guardant Health|Indikator likuiditas cepet guardanthealth.com

- indikator pendapatan resik lan kelipatan nilai:

GH - Bathi sawise mbayar pajeg|Bathi mangsa ngarep Guardant Health, Inc.|GH - Nilai perusahaan marang bathi resik|Pangali Forward P/E Guardant360|GH - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Guardant Corp|GH - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Guardant Health|GH - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan guardanthealth.com|GH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Guardant Health, Inc.

- data total pendapatan lan volume dodolan:

GH - Total dodolan perusahaan|Prakiraan volume dodolan Guardant Health|GH - Rasio kapitalisasi pasar marang pendapatan|Multiplikator forward rega marang pendapatan Guardant Corp

Pambiji fundamental perusahaan:Guardant Health GH

The forward P/S ratio reflects the market value of assets through the lens of discounted future cash flows, allowing investors to assess the premium paid for expected revenue growth. When analyzing the projected P/S valuation, it is essential to note that the metric's dynamics for Guardant Health, Inc. (GH) depend directly on the scaling of liquid biopsy sales and the demand for high-tech oncology tests within targeted therapy and pharmaceuticals.

Pesaing Guardant Health, Inc.

Rasio rega marang prakiraan pendapatan Caris Life Sciences CAI|Rasio kapitalisasi marang dodolan sing dikarepake Veracyte Inc (VCYT)|Celcuity Corp - Multiplikator Forward P/S|Prakiraan rega marang pendapatan GRAIL Bio (GRAL)|MYGN (Myriad Genetics, Inc.) - Multiplikator forward rega marang pendapatan|castlebiosciences.com (CSTL) - Multiplikator Forward P/S|BNR (Burning Rock) - Multiplikator Forward P/S|Multiplikator Forward P/S VolitionRx Ltd|Rasio rega marang prakiraan pendapatan Biodesix Corp (BDSX)|PRPO (Precipio Inc) - Rega forward marang dodolan|Multiplikator Forward P/S CHEK (Check-Cap)|MYNZ: Kapitalisasi marang prakiraan pendapatan|OncoCyte - Multiplikator Forward P/S